CV Sciences Inc (CVSI)

[SweetEquity]

FDA-Gottlieb Resigns-CBD Policy


Quotations taken from the article above:

"Gottlieb suggested a theoretical system in which concentration limits could be put on CBD-infused products, so that only high-potency CBD products would have to seek FDA approval."

"Jonathan Havens, co-chair of the cannabis law practice at Saul Ewing Arnstein & Lehr, to CNBC."

"Havens expanded on this in an interview with Cannabis Business Times, saying that the FDA “acknowledged that there’s a lot of attention in the space, and that the agency would possibly consider pursuing regulation to allow CBD as a dietary ingredient."

"But an announcement from commissioner Gottlieb in February showed signs that the hardline approach might be softening; speaking to the House Appropriations Committee, Gottlieb revealed that the FDA was planning to hold a public meeting in April for the purpose of revisiting its stance on CBD policy." [The FDA has since announced the public meeting will be in May].

"In the meantime, CBD companies are being advised to protect themselves from any FDA reprimands by making sure to not make any claims about the effects of their product that cannot be backed up by study and research. Misleading claims or marketing have resulted in several companies already receiving warning notices from the FDA. The FDA also has the power to issue fines, remove products from shelves, and even close down the businesses of repeat offenders"